GlassScriptPhysician profile
Phalashia Browning
NPI 1619550274
$1,363.40
in general payments reported to CMS, 2019-2025
18 companies · $517 in 2025
The $517 reported for 2025 was more than what 84% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.58 · 2022: $303 · 2023: $278 · 2024: $184 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.30 | 2021-2025 | |
| Astellas Pharma US INC | $167.24 | 2023-2025 | Veozah |
| Xeris Pharmaceuticals, INC. | $121.87 | 2025 | Recorlev |
| Axsome Therapeutics, INC. | $119.17 | 2025 | Auvelity |
| Ethicon US, LLC | $114.63 | 2025 | Evarrest, Dermabond, Surgicel Nu-Knit |
| Myovant Sciences INC. | $88.20 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.69 | 2025 | Jardiance |
| Sumitomo Pharma America, INC. | $72.33 | 2023 | Myfembree |
| Exeltis, USA INC. | $68.67 | 2022-2024 | Slynd |
| Mylan Pharmaceuticals INC. | $64.91 | 2021-2022 | |
| Organon LLC | $48.53 | 2021-2023 | Nexplanon |
| Coopersurgical, INC. | $32.70 | 2022-2023 | Paragard T 380a |
| Exact Sciences Corporation | $26.40 | 2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $24.55 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $23.26 | 2023 | Affirm Prone Biopsy System, Aptima, Thinprep 2000 Processor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $22.30 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.04 | 2022 | |
| Pfizer INC. | $17.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phalashia Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.